SCHEMBL5754075

SCHEMBL5754075

O=C(O)c1ccc(C=Cc2ccc(Cl)cc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.74
ALOX15 P16050 1/20 0.74
SRD5A2 P31213 1/20 0.65
CYP1A2 P05177 1/20 0.57
MAOB P27338 3/20 0.56
CYP1B1 Q16678 1/20 0.56
ALDH1A1 P00352 2/20 0.56
KMT2A Q03164 2/20 0.55
MEN1 O00255 1/20 0.55
DUSP3 P51452 1/20 0.55
PTPN5 P54829 1/20 0.55
PTPN11 Q06124 1/20 0.55
CXCL12 P48061 1/20 0.55
FBP1 P09467 1/20 0.53
MAOA P21397 1/20 0.53
TP53 P04637 1/20 0.52
EBP Q15125 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5754068 1.00 TSHR (0.74) TSHRALOX15SRD5A2CYP1A2MAOB
Benzoic Acid SCHEMBL18050330 0.92 MAOB (0.68) TSHRALOX15SRD5A2CYP1A2MAOB
SCHEMBL69166 0.89 ALDH1A1 (0.68) TSHRALOX15SRD5A2ALDH1A1KMT2A
SCHEMBL2126364 0.89 ALDH1A1 (0.68) TSHRALOX15SRD5A2ALDH1A1KMT2A
SCHEMBL9339856 0.89 ALDH1A1 (0.68) TSHRALOX15SRD5A2ALDH1A1KMT2A
SCHEMBL2615887 0.89 ALDH1A1 (0.68) TSHRALOX15SRD5A2ALDH1A1KMT2A
SCHEMBL9681086 0.89 ALDH1A1 (0.68) TSHRALOX15SRD5A2ALDH1A1KMT2A
SCHEMBL69167 0.89 ALDH1A1 (0.68) TSHRALOX15SRD5A2ALDH1A1KMT2A
SCHEMBL9681088 0.89 ALDH1A1 (0.68) TSHRALOX15SRD5A2ALDH1A1KMT2A
SCHEMBL9078494 0.89 ALDH1A1 (0.68) TSHRALOX15SRD5A2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed
US-5998433-A THERAPY FOR HYPERLIPIDEMIA; ATHEROSCLEROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-12-07 US disclosed
CN-1160403-A Substd. heterobicyclic alkyl amines and their use as squalene oxide cyclase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1997-09-24 CN disclosed
EP-0785939-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 1997-07-30 EP disclosed
WO-1996011201-A1 SUBSTITUTED HETEROBICYCLIC ALKYL AMINES AND THEIR USE AS SQUALENE OXIDE CYCLASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP TSHR 3729/4885ALOX15 1837/4885SRD5A2 349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.